BMT-080676

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBMT-080676
Drug Alias NamemGluR2 positive allosteric modulator(sanofi-aventis)metabotropic glutamate receptor 2 positive allosteric modulators (Sanofi)metabotropic glutamate receptor 2 positive allosteric modulators (sanofi-aventis)BMT-080676
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 agonists
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsSchizophreniaCognition DisordersMental Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsSchizophreniaCognition DisordersMental Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A